Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction

Journal of Sexual Medicine

Volumn 7, Issue 10, 2010, Pages 3487-3494

  Porst, Hartmut ^a   Glina, Sidney ^b   Ralph, David ^c   Zeigler, Haoyue ^d   Wong, David G ^d   Woodward, Brad ^d  

^a Private Urological Practice   (Germany)

^b HOSPITAL IPIRANGA   (Brazil)

^c The Institute of Urology   (Germany)

^d Lilly Corporate Center   (United States)

Author keywords

Daily Low Dose PDE5 Inhibitor Therapy; Durability; Erectile Dysfunction; Response to Treatment; Sustainability; Tadalafil

Indexed keywords

TADALAFIL;

ADULT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION ERECTILE FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PENIS ERECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 77957346199     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01908.x     Document Type: Article

References (9)

1. Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata AR, Maggi M, Mansani R, Palego P, Spera G, Vetri M, Lenzi A. The ENDOTRIAL study: A spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. J Sex Med 2009, 6:2547-60. Endotrial Study Group
2. Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: A pilot study. Int J Impot Res 2007, 19:200-7.
3. Aversa A, Caprio M, Rosano GM, Spera G. Endothelial effects of drugs designed to treat erectile dysfunction. Curr Pharm Des 2008, 14:3768-78.
4. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005, 47:214-20.
5. Zumbé J, Porst H, Sommer F, Grohmann W, Beneke M, Ulbrich E. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: Findings of the RESTORE Study. Eur Urol 2008, 54:204-10.
6. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008, 54:924-31.
7. Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 2006, 50:351-9.
8. Porst H, Rajfer J, Cassabe A, Fieldman R, Ralph D, Vieiralves LF, Esler A, Wolka AM, Klise SR. Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. J Sex Med 2008, 5:2160-9.
9. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for the assessment of erectile dysfunction. Urology 1997, 49:822-30.